The National Academies are responding to the COVID-19 pandemic.
Visit our resource center >>
In the face of the unprecedented challenges created by the COVID-19 pandemic and the accompanying global public health emergency, the National Academy of Medicine’s Action Collaborative on Countering the U.S. Opioid Epidemic is giving its attention to this issue.
The COVID-19 pandemic has brought unprecedented challenges to our nation and the world. Many are working tirelessly to protect the health and well-being of individuals with substance use disorders and/or who experience pain—patient populations who are at high risk of contracting COVID-19 or having their continuum of care seriously disrupted during this outbreak.
The National Academy of Medicine’s Action Collaborative on Countering the U.S. Opioid Epidemic is focusing on this critical issue and remains wholly committed to supporting the health and well-being of individuals with substance use disorders and who experience pain.
The following resources offer more information on how to support patients and the clinicians who treat and manage the care of patients with substance use disorder and/or who experience pain during public health emergencies, including the COVID-19 response.
Resources from the NAM’s Action Collaborative on Countering the U.S. Opioid Epidemic
Supporting People with Addiction During COVID-19: A Free Webinar Series
A new webinar series from the NAM and the American Society of Addiction Medicine will provide insight and targeted guidance on how to ensure that individuals with addiction are cared for and protected during the ongoing public health crisis.
New Statement of Priorities for COVID-19
The COVID-19 pandemic is exacerbating ongoing public health emergencies, including the addiction crisis in the United States. During these challenging times, the National Academy of Medicine’s Action Collaborative on Countering the U.S. Opioid Epidemic remains wholly committed to supporting the health and well-being of individuals with substance use disorders (SUDs), including opioid use disorder, and chronic pain. These individuals are among the most at risk and susceptible to COVID-19, and their care and treatment are among the most disrupted by physical distancing and other measures that have been put into place to prevent the spread of the virus.
Members of the Action Collaborative’s Steering Committee have identified a series of priorities and strategies for providers, health systems, researchers, policymakers, regulators, and health leaders alike to preserve the health and well-being of individuals with SUD and chronic pain.
Resources on Addiction and Pain Management Services During COVID-19 by Source
Global Health Organizations
World Health Organization
Modes of Transmission of Virus Causing COVID-19: Implications for IPC Precaution Recommendations
U.S. Government Agencies
National Institute on Drug Abuse
Information and Guidance for Researcher, Clinicians, and the Public
Risks and Complications for Individuals with SUDs: A Call for Data and Research
Substance Abuse and Mental Health Services Administration
Federal Resources and Guidance for Substance Abuse and Mental Health Services
TAP 34: Disaster Planning Handbook for Behavioral Health Treatment Programs
Opioid Treatment Program (OTP) Guidance
Training and Technical Assistance Related to COVID-19
OTP Guidance for Patients Quarantined at Home with the Coronavirus
FAQs: Provision of methadone and buprenorphine for the treatment of Opioid Use Disorder in the COVID-19 emergency
Pandemic Response Resources
Associations and Organizations
Accreditation Council for Continuing Medical Education
COVID-19 Educator Resources: Continuing Education Tips and Tools
COVID-19 Clinician Resources: Continuing Education and Clinical Resources Organized by Topic
American Academy of Family Physicians
COVID-19 Resources, Activities, and Updates for Primary Care Physicians
American Academy of Pain Medicine
COVID-19 Resources for Pain Medicine Professionals
American College of Physicians
Coronavirus Disease 2019 (COVID-19): Information for Internists [Collated Resources Page]
COVID-19: An ACP Physician’s Guide + Resources
American Medical Association
Patient care for SUD, mental illness, chronic pain during COVID-19
American Society of Addiction Medicine (Updated 9/22/2020)
Caring for Patients During the COVID-19 Resources
Covid-19: Adjusting Drug Testing Protocols
Covid-19: Ensuring Access to Care in Opioid Treatment Programs
Covid-19: Infection Control and Mitigation Strategies in Residential Treatment Facilities
Covid-19: Infection Mitigation in Outpatient Settings
Covid-19: Promoting Support Group Attendance
Covid-19: Supporting Access to Buprenorphine in Office-Based Settings
Covid-19: Supporting Access to Telehealth for Addiction Services: Regulatory Overview and General Practice Considerations
American Society of Anethesiologists
The Use of Personal Protective Equipment by Anesthesia Professionals During the COVID-19 Pandemic
Anesthesia Patient Safety Foundation
Perioperative Considerations for 2019 Novel Coronavirus (COVID-19)
Association of American Medical Colleges
Clinical Teaching and Learning Experiences without Physical Patient Contact
Collaborative Student Volunteer and Service Projects with Health Systems and Medical Schools
Association of State and Territorial Health Officials
ASTHO COVID-19 Resource Page
Medication Assisted Treatment (MAT) Guidance During COVID-19
Preventing Adverse Childhood Experiences During COVID-19
Avoiding ACEs by Helping Families During COVID-19
Federation of State Medical Boards
State and Federal Resources for Advocacy, Legislation, and Regulation
Kaiser Family Foundation
The Implications of COVID-19 for Mental Health and Substance Use
National Governors Association
Peer-Reviewed Journals, Textbooks, and Trade Press
American Journal of Preventative Medicine
Vulnerable Populations: Weathering the Pandemic Storm
Annals of Internal Medicine
Responding to the Opioid Crisis Appropriately in the Context of a Pandemic
Call to Action to Address the Adverse Effects of COVID-19 on Opioid Morbidity and Mortality
Collision of the COVID-19 and Addiction Epidemics
Elsevier
COVID-19:The Current and Future State of Mental Health Care
Health Affairs
Practice and Policy Considerations for Federal and State Authorities
Journal of Rural Health
COVID-19 During the Opioid Epidemic – Exacerbation of Stigma and Vulnerabilities
Journal of the International Association for the Study of Pain
Managing patients with chronic pain during the Covid-19 outbreak
Oxford Academic
A Framework for Pain Management Practitioners During the COVID-19 Pandemic
Pain Medicine
Springer
For questions on the Action Collaborative on Countering the U.S. Opioid Epidemic’s response to COVID-19, contact OpioidCollaborative@nas.edu.
Join our COVID-19 and Infectious Diseases and U.S. Opioid Epidemic mailing lists for related updates.
